Hepatocyte Growth Factor Enhances Antineoplastic Effect of 5-Fluorouracil by Increasing UPP1 Expression in HepG2 Cells

Aberrant activation of hepatocyte growth factor (HGF) and its receptor c-Met axis promotes tumor growth. Therefore, many clinical trials have been conducted. A phase 3 trial investigating a monoclonal antibody targeting HGF in combination with fluoropyrimidine-based chemotherapy had to be terminated...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumura, Manabu, Iwakiri, Tomomi, Yoshikawa, Naoki, Nagatomo, Takao, Ayabe, Takanori, Tsuneyoshi, Isao, Ikeda, Ryuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409026/
https://www.ncbi.nlm.nih.gov/pubmed/36012373
http://dx.doi.org/10.3390/ijms23169108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409026/
https://www.ncbi.nlm.nih.gov/pubmed/36012373
http://dx.doi.org/10.3390/ijms23169108

Ejemplares similares